SUCCESSFUL TREATMENT OF SOMNAMBULISM WITH OROS-METHYLPHENIDATE

被引：0
|
作者：
Nigam, M. [1 ,2 ]
Zadra, A. [1 ,3 ]
Boucetta, S. [1 ]
Gibbs, S. A. [1 ,2 ,4 ]
Warby, S. [1 ,5 ]
Montplaisir, J. [1 ,5 ]
Desautels, A. [1 ,2 ,4 ]
机构：
[1] Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, Montreal, PQ, Canada
[2] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada
[3] Univ Montreal, Dept Psychol, Montreal, PQ, Canada
[4] Hop Sacre Coeur Montreal, Neurol Serv, Montreal, PQ, Canada
[5] Univ Montreal, Dept Psychiat, Montreal, PQ, Canada
来源：
SLEEP MEDICINE | 2019年 / 64卷
基金：
加拿大健康研究院;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S279 / S280
页数：2
相关论文
共 50 条
  • [31] Time Course of Treatment Effect of OROS® Methylphenidate in Children With ADHD
    Armstrong, Robert B.
    Damaraju, C. V.
    Ascher, Steve
    Schwarzman, Lesley
    O'Neill, James
    Starr, H. Lynn
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (08) : 697 - 705
  • [32] Assessing Personality Disorder in Adults With ADHD, and its Effects on Response to Treatment with OROS® Methylphenidate (OROS® MPH)
    Robison, Reid
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Gale, Phillip
    Williams, Erika D.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 632 - 632
  • [33] The effects of transdermal methylphenidate with reference to OROS methylphenidate in ADHD
    Lopez, Frank A.
    Shingler, Tarra
    Heinlein, Kristen
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05) : 441 - 442
  • [34] Genetic imaging study with [Tc-99m] TRODAT-1 SPECT in adolescents with ADHD using OROS-methylphenidate
    Akay, Aynur Pekcanlar
    Kaya, Gamze Capa
    Kose, Samet
    Yazicioglu, Cigdem Eresen
    Erkuran, Handan Ozek
    Guney, Sevay Alsen
    Oguz, Kaya
    Keskin, Duygu
    Baykara, Burak
    Emiroglu, Neslihan Inal
    Eren, Mine Sencan
    Kizildag, Sefa
    Ertay, Turkan
    Ozsoylu, Dua
    Miral, Suha
    Durak, Hatice
    Gonul, Ali Saffet
    Rohde, Luis Augusto
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2018, 86 : 294 - 300
  • [35] ABCB1 c.2677G>T Variation Is Associated With Adverse Reactions of OROS-Methylphenidate in Children and Adolescents With ADHD
    Kim, So Won
    Lee, Ji Hyun
    Lee, Sung Hee
    Hong, Hyun Ju
    Lee, Min Goo
    Yook, Ki-Hwan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (04) : 491 - 498
  • [36] Assessment of cognitive domains during treatment with OROS methylphenidate in adolescents with ADHD
    Hammerness, Paul
    Fried, Ronna
    Petty, Carter
    Meller, Benjamin
    Biederman, Joseph
    CHILD NEUROPSYCHOLOGY, 2014, 20 (03) : 319 - 327
  • [37] OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder
    Antoni Ramos-Quiroga, J.
    Corominas, Margarida
    Castells, Xavier
    Bosch, Rosa
    Casas, Miguel
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2009, 9 (08) : 1121 - 1131
  • [38] OROS® methylphenidate treatment for ADHD:: Long-term effect on growth
    Biederman, J
    Stephen, F
    Spencer, T
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S274 - S274
  • [39] A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA®) and generic novo-methylphenidate ER-C (NOVO-generic)
    Fallu, Angelo
    Dabouz, Farida
    Furtado, Melissa
    Anand, Leena
    Katzman, Martin A.
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2016, 6 (04) : 237 - 251
  • [40] The Impact of Age on Treatment Response With OROS® Methylphenidate (MPH) in Adults With ADHD
    Starr, Harriet L.
    Goodman, David W.
    Damaraju, Chandrasekhar Rao V.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 637 - 637
12345